Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Madrigal Pharmaceuticals Inc
(NQ:
MDGL
)
258.81
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
17
Open
258.81
Bid (Size)
257.36 (1)
Ask (Size)
260.00 (1)
Prev. Close
258.81
Today's Range
258.81 - 258.81
52wk Range
119.76 - 322.67
Shares Outstanding
17,103,395
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
March 26, 2024
This biotech just got clearance to dive into a deep ocean of a market.
Via
The Motley Fool
This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?
March 22, 2024
The mid-cap biotech has succeeded where many others failed.
Via
The Motley Fool
Performance
YTD
+14.08%
+14.08%
1 Month
+11.28%
+11.28%
3 Month
+9.32%
+9.32%
6 Month
+70.85%
+70.85%
1 Year
+7.48%
+7.48%
More News
Read More
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
March 19, 2024
Via
The Motley Fool
Exposures
Product Safety
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
March 18, 2024
Via
InvestorPlace
Madrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark
March 18, 2024
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/15 Morning Trading
March 15, 2024
Via
Investor Brand Network
Madrigal Pharmaceuticals: Q4 Earnings Insights
February 28, 2024
Via
Benzinga
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
Via
The Motley Fool
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 15, 2024
Via
Benzinga
FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring
March 15, 2024
Via
Benzinga
Exposures
Product Safety
Why Is Geron (GERN) Stock Up 94% Today?
March 15, 2024
Via
InvestorPlace
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
March 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
MDGL Stock Alert: The Historic Reason Madrigal Is Up 19% Today
March 15, 2024
Via
InvestorPlace
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 15, 2024
Via
Benzinga
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
March 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 15, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 14, 2024
Via
Benzinga
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
Why Madrigal Stock, Which Has Gained 62% In A Month, Just Slumped Ahead Of A Potential First-Ever In MASH
March 14, 2024
Via
Investor's Business Daily
Missed Out on Eli Lilly? 3 Healthcare Stocks With Big Catalysts on the Horizon.
March 09, 2024
Via
The Motley Fool
1 Wall Street Analyst Thinks Madrigal Pharmaceuticals Stock Is Going to $347. Is It a Buy Around $247?
March 05, 2024
Via
The Motley Fool
Biotech Stocks Madrigal, Altimmune In A Tizzy As New Weight-Loss Rival Enters The Arena
February 26, 2024
Via
Investor's Business Daily
1 Beaten-Down Stock That Could Soar by 40%, According to Wall Street
February 23, 2024
Via
The Motley Fool
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
COVID-19
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.